Design and initiation of pivotal studies for Berubicin, a novel, potent topoisomerase II poison for the treatment of recurrent glioblastoma multiforme (GBM)

doxorubicin hydrochloride - Generic mfg.

berubicin (RTA 744) - CNS Pharma, WPD Pharma

lomustine - Generic mfg.

temozolomide - Generic mfg.

Sandra Silberman; Sigmund Hsu; Zena Muczyczenko; Donald Picker; Marek Sipowicz; Ewa Żak; Agnieszka Buczyńska; Mariusz Olejniczak; Waldemar Priebe

Nov 16, 2021